Why Better Therapeutics Are Trading Higher By 51%; Here Are 20 Stocks Moving Premarket

Gainers

CytoMed Therapeutics Limited GDTC shares surged 109.2% to $7.30 in pre-market trading after gaining 9% on Monday.
Better Therapeutics, Inc. BTTX shares gained 51.1% to $1.36 in pre-market trading after the FDA approved the company's AspyreRx prescription-only digital therapeutic treatment to provide cognitive behavioral therapy to adult patients with type 2 diabetes.
Crown ElectroKinetics Corp. CRKN shares rose 42.2% to $0.1450 in pre-market trading after declining around 14% on Monday.
Trinity Place Holdings Inc. TPHS gained 24.1% to $0.6790 in pre-market trading after declining around 15% on Monday.
TC Biopharm (Holdings) Plc TCBP shares rose 20.8% to $0.54 in pre-market trading.
NanoViricides, Inc. NNVC rose 19.9% to $1.69 in pre-market trading. NanoViricides reported effectiveness of antiviral clinical drug candidate NV-387 in an animal model of lethal lung infection with respiratory syncytial virus.
Acumen Pharmaceuticals, Inc. ABOS shares climbed 18.2% to $5.86 in pre-market trading. Acumen Pharmaceuticals recently announced it will present topline results from a Phase 1 trial of its candidate ACI193 at the Alzheimer's Association International Conference in July.
CN Energy Group. Inc. CNEY rose 15.6% to $0.2110 in pre-market trading after falling around 6% on Monday.
T2 Biosystems, Inc. TTOO gained 14.5% to $0.1811 in pre-market trading after jumping around 37% on Monday.
Caravelle International Group CACO shares gained 12.6% to $0.6190 in pre-market trading.

Losers

DSS, Inc. DSS fell 17.1% to $0.3002 in pre-market trading. DSS Wealth, Inc., a wholly owned subsidiary of DSS, Inc, named Daniel Lew as Chief Investment Officer and Portfolio Manager.
Viridian Therapeutics, Inc. VRDN fell 14.4% to $20.99 in pre-market trading after announcing data from ongoing Phase 1/2 trial evaluating VRDN-001 in patients with chronic thyroid eye disease.
Iovance Biotherapeutics, Inc. IOVA fell 12.5% to $7.69 in pre-market trading as the company priced its underwritten public offering of 20,000,000 shares at $7.50 per share.
Jupiter Wellness, Inc. JUPW fell 11.9% to $0.4845 in pre-market trading. Jupiter Wellness shares jumped over 50% on Monday after the company announced it has executed an Asset Purchase Agreement with GBB Drink Lab to acquire all operating assets including the "Safety Shot" rapid alcohol detox drink.
REE Automotive Ltd. REE shares dropped 10.5% to $0.34 in pre-market trading. REE Automotive recently named Carlton Rose, former global president of fleet maintenance and engineering at UPS, to the company’s board of directors.
Tattooed Chef, Inc. TTCF fell 10.1% to $0.1889 in pre-market trading after declining 19% on Monday. Tattooed Chef recently announced it intends to file for voluntary Chapter 11 Bankruptcy protection.
Journey Medical Corporation DERM shares fell 9.2% to $2.58 in pre-market trading after climbing around 21% on Monday.
EZFill Holdings Inc. EZFL fell 9.1% to $2.00 in pre-market. EzFill achieved another quarterly record for gallons delivered in the second quarter.
urban-gro, Inc. UGRO shares fell 8.1% to $1.83 in pre-market trading after rising around 5% on Monday.
Ryvyl Inc. RVYL fell 7.8% to $1.07 in pre-market trading after gaining over 5% on Monday.